Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants

Drug and Alcohol Review

Volumn 27, Issue 3, 2008, Pages 277-285

  McKetin, Rebecca ^a   Ross, Joanne ^a   Kelly, Erin ^a   Baker, Amanda ^b   Lee, Nicole ^c   Lubman, Dan I ^d   Mattick, Richard ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c Turning Point Drug and Alcohol Centre   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Injecting; Methamphetamine; Route of administration; Smoking; Substance use

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CENTRAL STIMULANT AGENT; METHAMPHETAMINE; STREET DRUG;

ADOLESCENT; ADULT; AGE; ARTICLE; AUSTRALIA; COMPARATIVE STUDY; CRIME; DISEASE TRANSMISSION; DRUG ABUSE; FEMALE; HEROIN DEPENDENCE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; SEX DIFFERENCE; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; AGE FACTORS; AMPHETAMINE-RELATED DISORDERS; AUSTRALIA; CENTRAL NERVOUS SYSTEM STIMULANTS; CRIME; DATA COLLECTION; FEMALE; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RISK-TAKING; SEX FACTORS; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 41549135639     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230801919486     Document Type: Article

References (45)

1. Barr AM, Panenka WJ, MacEwan GW, et al. The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 2006;31:301-13.
2. Jernigan T, Gamst A, Archibald S, et al. Effects of methamphetamine dependence and HIV infection on cerebral morphology. AmJ Psychiatry 2005;162:1461-72.
3. Nordahl T, Salo R, Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci 2003;15:317-25.
4. Woods S, Rippeth J, Conover E, et al. Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology 2005;19:35-43.
5. Kaye S, McKetin R, Darke S, Duflou J. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007;102:1024 - 11.
6. Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. Br J Psychiatry 2004;185:196-204.
7. Buchacz K, McFarland W, Kellogg TA, et al. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS 2005;19:1423-4.
8. Burcham JL, Tindall B, Marmor M, Cooper DA, Berry G, Penny R. Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual men. Med J Aust 1989;150:634-9.
9. Rawson RA, Washton A, Domier C, Reiber C. Drugs and sexual effects: role of drug type and gender. J Subst Abuse Treat 2002;22:103-8.
10. Zule WA, Costenbader EC, Meyer WJ Jr, Wechsberg WM. Methamphetamine use and risky sexual behaviors during heterosexual encounters. Sex Transm Dis 2007;34:689-94.
11. Molitor F, Ruiz JD, Flynn N, Mikanda JN, Sun RK, Anderson R. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse 1999;25:475-93.
12. Morin SF, Steward WT, Charlebois ED, et al. Predicting HIV transmission risk among HW-infected men who have sex with men: findings from the healthy living project. J Acquir Immun Defic Syndrome 2005;40:226-35.
13. Domier CP, Simon SL, Rawson RA, Huber A, Ling W. A comparison of injecting and noninjecting methamphetamine users. J Psychoact Drugs 2000;322:229-32.
14. Semple SJ, Patterson TL, Grant I. A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men. Drug Alcohol Depend 2004;76:203-12.
15. Gossop M, Griffiths P, Powis B, Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict 1992;87:1527-36.
16. Hall W, Hando J. Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug Alcohol Rev 1994;13:277-84.
17. Hall W, Hando J. Illicit amphetamine use as a public health problem in Australia. Med J Aust 1993;159:643-4.
18. Matsumoto T, Kamijo A, Miyakawa T, et al. Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. Addiction 2002;97:809-17.
19. McKetin R, McLaren J, Kelly E. The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug Alcohol Depend 2006;85:198-204.
20. Hillhouse MP, Marinelli-Casey P, Gonzales R, et al. Predicting in-treatment performance and post-treatment outcomes in methamphetamine users. Addiction 2007;102s:84-95.
21. Galloway GP, Marinelli-Casey P, Stalcup J, et al. Treatment-as-usual in the methamphetamine treatment project. J Psychoact Drugs 2000;32:165-75.
22. Vongsheree S, Sri-Ngam P, Ruchusatsawat N, et al. High HIV-1 prevalence among metamphetamine users in central Thailand, 1999-2000. J Med Assoc Thailand 2001;84:1263-7.
23. Szuster RR. Methamphetamine in psychiatric emergencies. Hawaii Med J 1990;49:389-91.
24. Cook CE, Jeffcoat AR, Hill JM, et al. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking s-(+)-methamphetamine hydrochloride. Drug Metab Dispos 1993;21:717-23.
25. Cho AK. Ice: a new dosage form of an old drug. Science 1990;249:631-4.
26. Cho AK, Melega WP. Patterns of methamphetamine abuse and their consequences. J Addict Dis 2002;21:21-34.
27. Tohhara S, Kato A, Nakajima T. Methamphetamine abuse by smoking. Japanese J Alcohol Stud Drug Depend 1990;25:467-74.
28. Topp L, Degenhardt L, Kaye S, Darke S. The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system. Drug Alcohol Rev 2002;21:341 - 8.
29. Kinner SA, Degenhardt L. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm. Drug Alcohol Rev 2008;27:292-300.
30. Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia 2005 - 06: report on the National Minimum Data Set. Drug Treatment Series no. 7, AIHW Cat. no. HSE 53. Canberra: Australian Institute of Health and Welfare, 2007.
31. Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS) in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995;90:607-14.
32. Topp L, Mattick RP. Choosing a cutoff on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 1997;92:839 - 45.
33. Darke S, Ward J, Hall W, Heather N, Wodak A. The Opiate Treatment Index (OTT) manual. National Drug and Alcohol Research Centre Technical Report no. 11. Sydney: National Drug and Alcohol Research Centre, 1991.
34. Ware JE, Kosinksi MMA, Keller SD. How to score the SF-12 physical and mental health summary scales, 2nd edn. Boston: The Health Institute, New England Medical Centre, 1995.
35. Sanderson K, Andrews G. Prevalence and severity of mental health-related disability and relationship to diagnosis. Psychiatr Serv 2002;53:80-6.
36. Ware JE, Kosinksi MMA, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
37. Kessler RC, Andrews G, Colpe L, et al. Short screening sales to monitor population prevalences and trends in nonspecific psychologial distress. Cambridge, MA: Department of Health Care Policy, Harvard Medical School, 2000.
38. Lukoff D, Nuechterlein KH, Ventura J. Manual for the expanded Brief Psychiatric Rating Scale. Schizophr Bull 1986;12:594-602.
39. STATA Corporation, STATA/SE version 9.2 for Windows. Texas: STATA Corporation, 2006.
40. McKetin R, Kelly E. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia. Drug Alcohol Rev 2007;26:161-8.
41. Glantz MD, Pickens R. Vulnerability to drug abuse. Washington: American Psychological Association, 1992.
42. Baker A, Gowing L, Lee N, Proudfoot H. Psychosocial interventions. In: Baker A, Lee N, Jenner L, eds. Models of intervention and care for psychostimulant users. National Drug Strategy Monograph no. 51. Canberra: Commonwealth of Australia, 2004:63-84.
43. Des Jarlais DC. The first and second decades of AIDS among injecting drug users. Br J Addict 1992;87:347-53.
44. Hunt N, Stillwell G, Taylor C, Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting. Drugs Educ Prev Policy 1998;5:185-94.
45. Fergusson DM, Horwood LJ, Ridder EM. Show me the child at seven: the consequences of conduct problems in childhood for psychosocial functioning in adulthood. J Child Psychol Psychiatry 2005;468:837-49.